Diabetic Cardiomyopathy Clinical Trial
Official title:
Impact of Prediabetes On Acute Coronary Syndrome in Sohag University Hospital
Verified date | July 2021 |
Source | Sohag University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational [Patient Registry] |
Diabetes mellitus is one of the chronic non-communicable diseases which have emerged as a leading global health problem. According to the International Diabetes Federation Atlas guideline report, currently, there are 352 million adults with impaired glucose tolerance who are at high risk of developing diabetes in the future. In 2017, it was estimated that 425 million people (20-79 years of age) suffered from Diabetes mellitus, and the number is expected to rise to 629 million by 2045. Moreover, Egypt is considered one of the top 10 countries in the world
Status | Completed |
Enrollment | 100 |
Est. completion date | August 23, 2022 |
Est. primary completion date | August 1, 2022 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: - All patients with acute coronary syndrome - Diabetic patients and will be subdivided into controlled and uncontrolled Pre-diabetic patients. - Non-diabetic patient(Controlled) Exclusion Criteria: - Patient under 18 years old - Pregnancy - Chronic kidney disease - Familiar hyperlipidemia. |
Country | Name | City | State |
---|---|---|---|
Egypt | Sohag University | Sohag |
Lead Sponsor | Collaborator |
---|---|
Sohag University |
Egypt,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Hba1c | We consider patients with Hba1c less than 5.7% not diabetic , Patients with Hba1c from 5.7%-6.4% prediabetic and patients with Hba1c 6.5% or more diabetic patients | Day 1 | |
Primary | CCU admission | All patients admitted with acute coronary syndrome will be included in the research | 6 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT00628056 -
Mechanisms Responsible for Cardiac and Skeletal Muscle Energetic Impairment in Diabetes
|
Phase 1/Phase 2 | |
Completed |
NCT01803828 -
REmodelling in Diabetic CardiOmapathy: Gender Response to PDE5i InhibiTOrs
|
Phase 4 | |
Active, not recruiting |
NCT03904485 -
Assessment of Myocardial Injury in Simultaneous Pancreas and Kidney Transplantation
|